Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
A vaccine causes the immune system to produce antibodies (immune response) to specific germs
to protect the patient. This study evaluates the immune response to the pneumococcal vaccine
in adults with Alefacept-treated chronic plaque psoriasis.